Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGEN Repligen Corporation

盘前交易 12-31 06:40:21 EST

166.59

+0.86

+0.52%

最高167.09	最低162.02	成交量31.94万
今开164.93	昨收165.73	日振幅3.06%
总市值93.77亿	流通市值87.72亿	总股本5,629万
成交额5,304万	换手率0.61%	流通股本5,266万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":166.59,"timestamp":1767128400000,"preClose":165.73,"halted":0,"volume":319440,"delay":0,"floatShares":52655397,"shares":56290749,"eps":0.025446,"marketStatus":"盘前交易","change":0.86,"latestTime":"12-31 06:40:21 EST","open":164.93,"high":167.09,"low":162.02,"amount":53042104.7904,"amplitude":0.030592,"askPrice":173.13,"askSize":5,"bidPrice":118.92,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.025446,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767191400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":166.59,"postHourTrading":{"tag":"盘后","latestPrice":166.59,"preClose":166.59,"latestTime":"18:49 EST","volume":14212,"amount":2367573.28,"timestamp":1767138556452},"volumeRatio":0.8306446078044778,"impliedVol":0.3775,"impliedVolPercentile":0.0602},"requestUrl":"/m/hq/s/RGEN","defaultTab":"news","newsList":[{"id":"2582369474","title":"Repligen Corporation盘中异动 早盘股价大涨5.36%报150.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582369474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582369474?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:45","pubTimestamp":1762785947,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时45分，Repligen Corporation股票出现波动，股价急速拉升5.36%。截至发稿，该股报150.48美元/股，成交量6.1717万股，换手率0.11%，振幅3.54%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.66%。其相关个股中，Nyxoah Sa、Microbot Medical Inc.、Repligen Corporation涨幅较大，Femasys Inc.、Microbot Medical Inc.、哈佛生物科学较为活跃，换手率分别为5.15%、0.77%、0.65%，振幅较大的相关个股有Nephros, Inc.、Femasys Inc.、Daxor Corporation，振幅分别为18.91%、9.59%、9.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224547a6efc45c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224547a6efc45c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU0757428866.USD","LU1815336091.USD","RGEN"],"gpt_icon":0},{"id":"1148168475","title":"异动解读 | 瑞普基因季报营收超预期，股价盘中大涨9.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148168475","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148168475?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:54","pubTimestamp":1753797298,"startTime":"0","endTime":"0","summary":"周二盘中，生物制药公司瑞普基因股价大涨9.34%，主要受益于公司公布的第二季度财报中营收数据优于市场预期。根据瑞普基因发布的财报显示，截至6月30日的第二季度，公司营收同比增长18.4%，达到1.8237亿美元，超过分析师预期的1.7502亿美元。尽管瑞普基因今年迄今股价累计下跌16.9%，但分析师对公司前景仍持乐观态度。这些积极因素可能进一步推动了投资者的买入热情，导致股价在财报发布后出现显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"gpt_icon":0},{"id":"1152262236","title":"异动解读 | 瑞普基因季报超预期，盘前大涨8.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152262236","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152262236?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:40","pubTimestamp":1753796416,"startTime":"0","endTime":"0","summary":"7月29日周二，生物制药公司瑞普基因盘前股价大涨8.40%，主要受益于公司公布的第二季度财报优于市场预期。根据瑞普基因发布的财报显示，截至6月30日的第二季度，公司调整后每股收益为0.37美元，虽略低于分析师平均预期的0.39美元，但高于去年同期的0.33美元。尽管公司股价在本季度下跌了3.8%，今年迄今为止累计下跌16.9%，但分析师对瑞普基因的前景仍持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"gpt_icon":0},{"id":"2555054467","title":"Repligen Corporation盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555054467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555054467?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:32","pubTimestamp":1753795927,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时32分，Repligen Corporation股票出现波动，股价快速上涨5.88%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.35%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213207a6c7f498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213207a6c7f498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN","LU1815336091.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2551187422","title":"Repligen Corporation盘中异动 早盘股价大跌5.09%报123.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187422?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:41","pubTimestamp":1752500467,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时41分，Repligen Corporation股票出现异动，股价快速跳水5.09%。截至发稿，该股报123.56美元/股，成交量7.0172万股，换手率0.12%，振幅3.60%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.18%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214107a6a8f428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214107a6a8f428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","LU0757428866.USD","BK4121","RGEN"],"gpt_icon":0},{"id":"2548883719","title":"Repligen Corporation盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883719?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:51","pubTimestamp":1751385073,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时51分，Repligen Corporation股票出现异动，股价大幅上涨5.02%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.48%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123511497961620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123511497961620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU0757428866.USD","LU1815336091.USD","BK4121"],"gpt_icon":0},{"id":"2545238089","title":"Repligen获巴克莱首次覆盖，给予增持评级, 目标价150.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545238089","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545238089?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:24","pubTimestamp":1750771483,"startTime":"0","endTime":"0","summary":"Repligen(RGEN.US)获巴克莱首次覆盖，给予增持评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624212755978ce78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624212755978ce78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2518827601","title":"Repligen Corporation盘中异动 快速下跌5.17%报147.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518827601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518827601?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:52","pubTimestamp":1741614761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时52分，Repligen Corporation股票出现异动，股价急速跳水5.17%。截至发稿，该股报147.65美元/股，成交量7.3314万股，换手率0.13%，振幅2.90%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.40%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121","LU0757428866.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2517605707","title":"Repligen Corporation盘中异动 股价大跌5.16%报147.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517605707?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:47","pubTimestamp":1741103262,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时47分，Repligen Corporation股票出现波动，股价大幅下跌5.16%。截至发稿，该股报147.37美元/股，成交量11.4499万股，换手率0.20%，振幅4.70%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.24%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU1815336091.USD","LU0757428866.USD","BK4121"],"gpt_icon":0},{"id":"2514703863","title":"Repligen Corporation盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703863?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:06","pubTimestamp":1740427594,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时06分，Repligen Corporation股票出现波动，股价快速拉升5.01%。截至发稿，该股报166.96美元/股，成交量47.4486万股，换手率0.85%，振幅5.20%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.23%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","BK4121","LU1815336091.USD","RGEN"],"gpt_icon":0},{"id":"2513097291","title":"小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513097291","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513097291?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:22","pubTimestamp":1740151334,"startTime":"0","endTime":"0","summary":"小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21232248320493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"gpt_icon":0},{"id":"2513262262","title":"加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262262","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513262262?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:40","pubTimestamp":1740141632,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21204048318756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"gpt_icon":0},{"id":"1103076426","title":"异动解读 | Repligen公司2024年Q4财报超预期,股价盘中涨逾9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103076426","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103076426?lang=zh_cn&edition=full","pubTime":"2025-02-21 03:48","pubTimestamp":1740080910,"startTime":"0","endTime":"0","summary":"上市生物科技公司Repligen(RGEN)今日盘中大涨9.48%,引发市场关注。这主要是由于公司新发布的2024年第四季度财报数据好于预期,带来了利好消息。\n\n根据财报显示,Repligen公司第四季度每股收益为0.44美元,超出了分析师预期的0.41美元。尽管公司当季销售额略低于预期,但盈利能力的显著提升,显示了公司良好的运营状况。\n\n分析人士认为,Repligen公司业绩超预期,增强了投资者对公司长期发展前景的信心。市场预期该公司将继续保持良好的增长动能,成为资本市场中的投资热点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"gpt_icon":0},{"id":"1179131861","title":"异动解读 | Repligen公司盘前大涨9.47%，业绩超预期带来市场利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1179131861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179131861?lang=zh_cn&edition=full","pubTime":"2025-02-20 21:54","pubTimestamp":1740059678,"startTime":"0","endTime":"0","summary":"上市生物科技公司Repligen(RGEN)今日盘前大涨9.47%,引发了市场投资者的广泛关注。\n\n消息面上,Repligen公司最新公布的2024年第四季度财报显示,公司当季每股收益为0.44美元,超出了分析师预期的0.41美元,同时公司销售额也略高于去年同期。尽管销售额低于分析师预期,但盈利能力的增长仍彰显出公司良好的运营状况。\n\n分析人士认为,Repligen公司的季度业绩好于市场预期,显示公司具有强劲的利润增长动力,这增强了投资者对公司长期前景的信心,从而刺激了公司股价在盘前大幅走高。展望未来,公司有望继续保持良好的业绩增长,成为资本市场的投资热点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"gpt_icon":0},{"id":"1124711795","title":"Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124711795","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124711795?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:39","pubTimestamp":1740055154,"startTime":"0","endTime":"0","summary":"Repligen  报告其季度每股收益为0.44美元，高于分析师普遍预期的0.41美元，高出7.32%。公司报告其季度销售额为1.6755亿美元，低于分析师普遍预期的1.6767亿美元，低出0.07%。与去年同期的销售额1.6662亿美元相比，增长了0.56%。以上内容来自Benzinga Earnings专栏，原文如下：Repligen  reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.41 by 7.32 percent. This is a 8.33 percent decrease over earnings of $0.48 per share from the same period last year.  The company reported quarterly sales of $167.55 million which missed the analyst consensus estimate of $167.67 mill","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"gpt_icon":0},{"id":"2507650584","title":"Repligen Corporation盘中异动 下午盘急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507650584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507650584?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:06","pubTimestamp":1738177586,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时06分，Repligen Corporation股票出现波动，股价快速下挫5.10%。截至发稿，该股报165.36美元/股，成交量46.3634万股，换手率0.83%，振幅5.18%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.28%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030627a2339427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030627a2339427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU0757428866.USD","LU1815336091.USD","BK4121"],"gpt_icon":0},{"id":"2506751752","title":"Repligen Corporation盘中异动 快速上涨6.24%报178.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506751752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506751752?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074672,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Repligen Corporation股票出现异动，股价大幅拉升6.24%。截至发稿，该股报178.50美元/股，成交量3.5001万股，换手率0.06%，振幅0.00%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.61%。其相关个股中，Daxor Corporation、Repligen Corporation、Avantor, Inc.涨幅较大，Sharps Technology Inc.、Glucotrack, Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为223.91%、9.98%、0.89%，振幅较大的相关个股有Glucotrack, Inc.、Zentek Ltd.、Daxor Corporation，振幅分别为2.52%、1.75%、1.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822311298756b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822311298756b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","LU0757428866.USD","BK4121","RGEN"],"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KHC","TER","SMCI","FSLR","MRNA","HTHT","CHDN","TSCO","WYNN","LU0757428866.USD","ONC","DOCU","ALAB","ROST","NICE","PFG","LSTR","SRPT","SQQQ","INTC","CASY","TCOM","HQY","CHRW","AKAM","CSGP","CZR","HSIC","MDB","MSFT","QID","MMYT","SNPS","AGNC","WBA","MKSI","GRAB","PAYX","ALNY","SBAC","TW","QXO","AMD","GMAB","NDAQ","PCTY","PDD","STLD","SBUX","AMGN","PNFP","RPRX","LU0053671581.USD","RADX","LNW","CSCO","RGLD","TSLA","DSGX","ERIE","KDP",".IXIC","BK4561","CRWD","Z","COKE","MCHP","NTRS","TXN","USJW.SI","WTFC","ESLT","FWONK","LIN","PLTR","MPWR","NTNX","COIN","AVGO","BSY","AAON","DDOG","PARA","CHRD","HLNE","MANH","MRVL","DASH","DKNG","ENTG","AAPL","MTSI","CHTR","MELI","NVMI","AMAT","PTC","ORLY","MIDD","EVRG","CWST","AXON","WWD","NFLX","META","BMRN","FTAI","BK4581","BRKR","POOL","MEDP","DUOL","PAA","PCAR","ROP","TPG","QRVO","TTEK","IDXX","FTNT","GNTX","REGN","SSNC","CSX","EBAY","PCVX","CINF","MKTX","LU1815336091.USD","ARGX","BK4534","MTCH","ISRG","ANSS","NTES","OLED","ERIC","DOX","NTAP","RIVN","ROKU","CME","LAMR","LI","BKNG","ADSK","REG","BPMC","MNDY","EXE","FOXA","SOFI","TEAM","CTSH","FCNCA","LPLA","CHKP","BK4086","ENPH","QQQ","TSYW.SI","HST","TQQQ","ICLR","NXPI","EWBC","CYBR","CEG","NDSN","PEP","DPZ","TRMB","MARA","ZS","QCOM","HOLX","CCEP","EXPE","LECO","AAL","APA","CBSH","JKHY","LOGI","INSM","PODD","TTD","FER","CG","AMZN","GEN","STX","SWKS","ADBE","ARM","ILMN","NVDA","GTLB","ASML","HOOD","GILD","SIRI","INCY","ULTA","NTRA","NWSA","TECH","ROIV","TTWO","COO","LU2065731478.USD","JD","MNST","MNQmain","CDW","FSV","LULU","COST","EA","ITCI","BPOP","LNT","RYAAY","USAW.SI","BK4550","TROW","CPB","LSCC","ZM","BK4585","LKQ","NVIW.SI","RGEN","FRPT","HBAN","QLD","SEIC","BK4588","AUR","EXAS","BIIB","BK4593","CDNS","SFM","MDLZ","CPRT","RKLB","AFRM","OTEX","TMUS","WDC","PSQ","DLTR","ADI","TLN","FYBR","FAST","GEHC","OKTA","CSWI","FFIV","GLPI","HON","FOX","CFLT","BKR","INTU","AEP","CTAS","ODFL","NBIX","GOOGL","EQIX","NQmain","ON","AZN","RVMD","SAIA","ALGN","JBHT","TSEM"],"gpt_icon":1},{"id":"2501252085","title":"Repligen Corporation盘中异动 快速拉升5.10%报157.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501252085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501252085?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:07","pubTimestamp":1736176065,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时07分，Repligen Corporation股票出现波动，股价急速拉升5.10%。截至发稿，该股报157.55美元/股，成交量7.6951万股，换手率0.14%，振幅5.00%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为1.15%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106230745a2179f12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106230745a2179f12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","BK4121","LU0757428866.USD","RGEN"],"gpt_icon":0},{"id":"2500286451","title":"Repligen Corporation盘中异动 下午盘快速上涨5.04%报150.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500286451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500286451?lang=zh_cn&edition=full","pubTime":"2025-01-04 02:18","pubTimestamp":1735928335,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日02时18分，Repligen Corporation股票出现波动，股价急速拉升5.04%。截至发稿，该股报150.26美元/股，成交量20.6913万股，换手率0.37%，振幅5.24%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为1.34%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010402185595f7f39b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010402185595f7f39b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","LU0757428866.USD","BK4121","RGEN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.1425},{"period":"6month","weight":0.3069},{"period":"1year","weight":0.1584},{"period":"ytd","weight":0.1574}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0053},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.0986},{"period":"1year","weight":0.1679},{"period":"ytd","weight":0.1722}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约，并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品，这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验，公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究，弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外，公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.096098},{"month":2,"riseRate":0.410256,"avgChangeRate":0.029809},{"month":3,"riseRate":0.538462,"avgChangeRate":0.034504},{"month":4,"riseRate":0.487179,"avgChangeRate":-0.003291},{"month":5,"riseRate":0.55,"avgChangeRate":0.045851},{"month":6,"riseRate":0.475,"avgChangeRate":-0.011153},{"month":7,"riseRate":0.5,"avgChangeRate":0.029297},{"month":8,"riseRate":0.575,"avgChangeRate":0.029951},{"month":9,"riseRate":0.375,"avgChangeRate":-0.036497},{"month":10,"riseRate":0.475,"avgChangeRate":0.025712},{"month":11,"riseRate":0.475,"avgChangeRate":0.032931},{"month":12,"riseRate":0.475,"avgChangeRate":-0.00332}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}